Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | EVP, GC, Chief Admin Off & Sec | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,059 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Gift · Disposed 18,407 · Balance 78,059 F1: On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 111,831 |
Reported balance
After 2026-06-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-09 · Gift · Acquired 18,407 · Balance 111,831 F1: On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. F2: The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust.
F2: The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 10, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GiftCommon Stock | 18,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-266014 · ownership.xml · nonDerivative · entry 2 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 111,831 F1 · shares: On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. F2 · ownership.nature: The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GiftCommon Stock | 18,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-266014 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,059 F1 · shares: On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 11,944 | $21.54 | $257,273.76 |
DisclosureSEC source: 0001193125-26-255703 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,466 F1 · kind: Represents 11,944 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| May 11, 2026 Filed May 13, 2026 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GiftCommon Stock | 40,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-221884 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,410 F1 · shares: On May 11, 2026 the reporting person transferred 40,826 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 26,931 | $19.85 | $534,580.35 |
DisclosureSEC source: 0001193125-26-088621 · ownership.xml · nonDerivative · entry 2 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,236 F2 · kind: Represents 26,931 shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 39,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088621 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,167 F1 · kind: Represents shares awarded pursuant to the satisfaction of performance conditions per the terms of a performance-based restricted share program established on March 1, 2023. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GiftCommon Stock | 10,371 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-085534 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,242 F1 · shares: On June 10, 2025 the reporting person transferred 10,371 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 6,729 | $14.15 | $95,215.35 |
DisclosureSEC source: 0000950170-25-081076 · ownership.xml · nonDerivative · entry 2 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,613 F2 · kind: Represents 6,729 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 53,004 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081076 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,342 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GiftCommon Stock | 26,497 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-035657 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,338 F1 · shares: On March 6, 2025 the reporting person transferred 26,497 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 8,975 | $14.77 | $132,560.75 |
DisclosureSEC source: 0000950170-25-032358 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,835 F1 · kind: Represents 8,975 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 8,108 | $16.00 | $129,728.00 |
DisclosureSEC source: 0000950170-24-125616 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, GC, Chief Admin Off & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,810 F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $16.00 to $16.03 for a weighted average sales price of $16.00. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 68,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-068803 · ownership.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,918 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2025, twenty-five percent (25%) of the restricted shares will vest on June 1, 2026 and fifty percent (50%) of the restricted shares will vest on June 1, 2027, subject to the terms of the Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 5,867 | $9.15 | $53,683.05 |
DisclosureSEC source: 0001209191-24-004387 · doc4.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,518 F1 · kind: Represents 5,867 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 970 | $9.62 | $9,331.40 |
DisclosureSEC source: 0001209191-23-058804 · doc4.xml · nonDerivative · entry 2 Moore Mary Ann E · CIK 0001894731 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,385 Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,150 | $9.62 | $11,063.00 |
DisclosureSEC source: 0001209191-23-058804 · doc4.xml · nonDerivative · entry 1 Moore Mary Ann E · CIK 0001894731 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 15,730 F1 · ownership.nature: The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 2,345 | $15.74 | $36,910.30 |
DisclosureSEC source: 0001209191-23-015668 · doc4.xml · nonDerivative · entry 3 Moore Mary Ann E · CIK 0001894731 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,355 F4 · kind: Represents 2,345 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 55,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015668 · doc4.xml · nonDerivative · entry 2 Moore Mary Ann E · CIK 0001894731 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,700 F2 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan. F3 · balance_after: Excludes 16,340 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 1,525 | $23.47 | $35,791.75 |
DisclosureSEC source: 0001209191-22-015593 · doc4.xml · nonDerivative · entry 4 Moore Mary Ann E · CIK 0001894731 · EVP Chief ERM/Legal Ops Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,376 F4 · kind: Represents 1,525 restricted shares withheld for payment of taxes upon vesting of shares. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 16,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015593 · doc4.xml · nonDerivative · entry 3 Moore Mary Ann E · CIK 0001894731 · EVP Chief ERM/Legal Ops Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,901 F3 · kind: Restricted shares granted pursuant to the Plan in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 8,170 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2022. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2023, twenty-five percent (25%) on March 1, 2024 and fifty percent (50%) on March 1, 2025, subject to the terms of the Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:00 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 16,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015593 · doc4.xml · nonDerivative · entry 2 Moore Mary Ann E · CIK 0001894731 · EVP Chief ERM/Legal Ops Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,561 F2 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2023, twenty-five percent (25%) of the restricted shares will vest on March 1, 2024 and fifty percent (50%) of the restricted shares will vest on March 1, 2025, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.